Optimization and characterization of biomolecule immobilization on silicon substrates using (3-aminopropyl) triethoxysilane (APTES) and glutaraldehyde linker NSK Gunda, M Singh, L Norman, K Kaur, SK Mitra Applied Surface Science 305, 522-530, 2014 | 321 | 2014 |
Microfluidic cantilever detects bacteria and measures their susceptibility to antibiotics in small confined volumes H Etayash, MF Khan, K Kaur, T Thundat Nature communications 7 (1), 12947, 2016 | 173 | 2016 |
Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal LM Sayre, W Sha, G Xu, K Kaur, D Nadkarni, G Subbanagounder, ... Chemical research in toxicology 9 (7), 1194-1201, 1996 | 134 | 1996 |
Peptide–drug conjugates with different linkers for cancer therapy M Alas, A Saghaeidehkordi, K Kaur Journal of medicinal chemistry 64 (1), 216-232, 2020 | 130 | 2020 |
HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in … RG Salomon, K Kaur, E Podrez, HF Hoff, AV Krushinsky, LM Sayre Chemical research in toxicology 13 (7), 557-564, 2000 | 130 | 2000 |
Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein D Raghuwanshi, V Mishra, D Das, K Kaur, MR Suresh Molecular pharmaceutics 9 (4), 946-956, 2012 | 125 | 2012 |
Dynamic relationships among type IIa bacteriocins: temperature effects on antimicrobial activity and on structure of the C-terminal amphipathic α helix as a receptor-binding region K Kaur, LC Andrew, DS Wishart, JC Vederas Biochemistry 43 (28), 9009-9020, 2004 | 119 | 2004 |
Isolevuglandin–protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway RG Salomon, E Batyreva, K Kaur, DL Sprecher, MJ Schreiber, JW Crabb, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2000 | 112 | 2000 |
Impedimetric detection of pathogenic gram-positive bacteria using an antimicrobial peptide from class IIa bacteriocins H Etayash, K Jiang, T Thundat, K Kaur Analytical chemistry 86 (3), 1693-1700, 2014 | 110 | 2014 |
Sustained drug release and antibacterial activity of ampicillin incorporated poly (methyl methacrylate)–nylon6 core/shell nanofibers A Sohrabi, PM Shaibani, H Etayash, K Kaur, T Thundat Polymer 54 (11), 2699-2705, 2013 | 108 | 2013 |
(Carboxyalkyl) pyrroles in human plasma and oxidized low-density lipoproteins K Kaur, RG Salomon, J O'Neil, HF Hoff Chemical research in toxicology 10 (12), 1387-1396, 1997 | 97 | 1997 |
Real-time detection of breast cancer cells using peptide-functionalized microcantilever arrays H Etayash, K Jiang, S Azmi, T Thundat, K Kaur Scientific reports 5 (1), 13967, 2015 | 93 | 2015 |
Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity M Shahin, R Soudy, HM Aliabadi, N Kneteman, K Kaur, A Lavasanifar Biomaterials 34 (16), 4089-4097, 2013 | 90 | 2013 |
Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel M Shahin, S Ahmed, K Kaur, A Lavasanifar Biomaterials 32 (22), 5123-5133, 2011 | 89 | 2011 |
Nanomechanical sandwich assay for multiple cancer biomarkers in breast cancer cell-derived exosomes H Etayash, AR McGee, K Kaur, T Thundat Nanoscale 8 (33), 15137-15141, 2016 | 85 | 2016 |
Proteolytically stable cancer targeting peptides with high affinity for breast cancer cells R Soudy, A Gill, T Sprules, A Lavasanifar, K Kaur Journal of medicinal chemistry 54 (21), 7523-7534, 2011 | 83 | 2011 |
Small peptide ligands for targeting EGFR in triple negative breast cancer cells H Hossein-Nejad-Ariani, E Althagafi, K Kaur Scientific reports 9 (1), 2723, 2019 | 80 | 2019 |
Levuglandin E2−Protein Adducts in Human Plasma and Vasculature RG Salomon, G Subbanagounder, J O'Neil, K Kaur, MA Smith, HF Hoff, ... Chemical research in toxicology 10 (5), 536-545, 1997 | 78 | 1997 |
Breast cancer targeting peptide binds keratin 1: a new molecular marker for targeted drug delivery to breast cancer R Soudy, H Etayash, K Bahadorani, A Lavasanifar, K Kaur Molecular pharmaceutics 14 (3), 593-604, 2017 | 75 | 2017 |
Peptide arrays for screening cancer specific peptides S Ahmed, AS Mathews, N Byeon, A Lavasanifar, K Kaur Analytical chemistry 82 (18), 7533-7541, 2010 | 74 | 2010 |